September 19, 2019
The Japan arm of GlaxoSmithKline said on September 17 that it has launched clinical research for the electric patient-reported outcome (ePRO) platform for the prevention of COPD exacerbations. The ePRO platform enables COPD patients to enter their conditions at home...read more